eye treatment biosimilar

South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...

Startups in the pet industry are gaining traction on the back of a rising number of pet owners in South Korea. Industry insiders say several pe...

South Korea’s food data analysis firm Nuvilab, Inc. is not a household name – at least yet. The startup is rather familiar to investors...

South Korea’s first-generation game developer NHN Corp. is gearing up to regain its past glory as the leader of the game industry.The tech gia...

SK Inc., the investment-focused holding company of South Korea’s SK Group, is set to pocket a sixfold return from its investment in SES Holdin...

South Korea's IMM Investment Corp. has agreed to invest 140 billion won ($120 million) in Iyuno-SDI Group, valuing the world's largest dubbing and s...

Hyundai Engineering Co., the plant engineering and construction unit of South Korea’s Hyundai Motor Group, dropped a listing plan to raise up ...

South Korea's HDC Hyundai Development Co. plans to raise more than 1 trillion won ($832 million) in funding backed by its real estate holdings as th...

The initial public offering of South Korea's LG Energy Solution Ltd. drew a record 11,500 trillion won ($9.65 trillion) in bids from institutional i...

Mirae Asset Financial Group, South Korea’s capital market giant, is set to enter the digital asset business, starting with a digital asset cus...

A robot with a humanoid arm is busy at work transporting parts inside Doosan Robotics’ manufacturing plant in Suwon City, Gyeonggi Province.&n...

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

Korea Investment Corporation (KIC) aims to increase alternative investment to 25% of its total investment by 2025 as well as rank among the world's ...

The Export-Import Bank of Korea (KEXIM) is planning to sell up to $3 billion worth of new global bonds this week, tipped to be the largest-ever bond...

South Korea’s top automaker Hyundai Motor Group on Monday set out its vision to be a top-tier eco-friendly auto brand with its focus on electr...

South Korea’s retail investors on Tuesday dumped 3.16 trillion won ($2.7 billion) worth of shares on the country’s two main stock market...

Paris Baguette, South Korea’s top bakery franchise, has successfully settled in the US market, paving the way to expand its business throughou...

Kyobo Life Insurance Co. on Tuesday applied for a preliminary review of its public listing with the Korea Exchange, three years after it canceled th...

Global memory chipmakers, including market leader Samsung Electronics Co., expect the current industry downcycle to be shorter than expected, with v...

South Korean SK Biopharmaceuticals Co. launched its epilepsy treatment Cenobamate in the UK, rapidly expanding the company’s presence in Europ...

Cosmax East, which owns and manages Cosmax’s business in China in its entirety, has announced plans to seek listing on the Korea Stock Exchang...

Michael ByungJu Kim, the founder of South Korean investment firm MBK Partners, and Kim Jung-ju, founder of Nexon, the largest online gaming compan...

Naviworks Co., a South Korean developer of virtual reality-based military training software, looks set to join a growing pool of metaverse-themed st...

Halla Group’s newly-launched autonomous driving solutions subsidiary HL Klemove targets 4 trillion won ($3.4 billion) in revenue by 2030 by ac...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Olim Planet, a South Korean property technology startup, has begun the process to go public on the junior Kosdaq market as early as the second half ...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Hyundai Engineering Co., Hyundai Motor Group’s construction arm, has joined the race to buy a South Korean garbage treatment company as the gr...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...